The present invention relates to spirocyclic acylguanidines and their use as inhibitors of the β-secretase enzyme (BACE1) activity, pharmaceutical compositions containing the same, and methods of using the same as therapeutic agents in the treatment of neurodegenerative disorders, disorders characterized by cognitive decline, cognitive impairment, dementia and diseases characterized by production of β-amyloid aggregates.
US9526727B2
申请人:——
公开号:US9526727B2
公开(公告)日:2016-12-27
A mild and efficient method for the preparation of guanidines
作者:Michael A. Poss、Edwin Iwanowicz、Joyce A. Reid、James Lin、Zhengxiang Gu
DOI:10.1016/s0040-4039(00)61092-4
日期:1992.9
A mild and efficientmethod for the preparation of guanidines by reaction of an acylated thiourea with an amine followed by removal of the acyl group(s) from the intermediate acylguanidine is reported.